Clinical Trials Logo

Psychomotor Agitation clinical trials

View clinical trials related to Psychomotor Agitation.

Filter by:

NCT ID: NCT03926520 Recruiting - Alzheimer Dementia Clinical Trials

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

ECT-AD
Start date: January 28, 2021
Phase: N/A
Study type: Interventional

This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia including Alzheimer's Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies. The study will also determine the tolerability/safety outcomes of ECT+UC.

NCT ID: NCT03880084 Recruiting - Pain Clinical Trials

Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM)

NIVILIUM
Start date: August 1, 2019
Phase:
Study type: Observational

Non-Invasive Mechanical Ventilation (NIV) has been increasingly used in the treatment of acute respiratory failure. Notwithstanding failure rates still remains high, ranging from 5% to 60%. The onset of delirium, agitation, pain and dyspnea may contribute to reduce the success rate of non invasive ventilation treatment. The aim of this study is to assess the incidence and impact of delirium, agitation, pain and dyspnea on clinical outcomes in a population of patient admitted to Respiratory Intensive Care Unit undergoing Non-Invasive Mechanical Ventilation for Acute Respiratory Failure.

NCT ID: NCT03571867 Recruiting - Clinical trials for The Severity of Agitation in Adenotonsillectomy in Pediatric Patients

Comparison of The Severity of Agitation of Sugammadex and Atropine-Nesostigmine in Adenotonsillectomy

Start date: July 1, 2018
Phase:
Study type: Observational

the use of sugammadex during the reversal of neuromuscular blocking after adenotonsillectomy surgery in pediatric patients would be advantageous in terms of patient comfort and reducing side effects. Thus, we aimed to evaluate the time to extubation, agitation and pain scores in pediatric patients who underwent adenotonsillectomy and awakened with neostigmine and sugammadex in our study.

NCT ID: NCT03513549 Recruiting - Clinical trials for Agitation,Psychomotor

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Start date: November 4, 2014
Phase:
Study type: Observational

This postmarketing observational study will evaluate the safety of ADASUVE® in treating patients with agitation associated with schizophrenia or bipolar I disorder.

NCT ID: NCT03398759 Recruiting - Agitation Clinical Trials

Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Emergence agitation is one of the common postoperative complications after functional endoscopic sinus surgery(FESS). The objective of present study is to explore the effectiveness of butorphanol in the alleviation of emergence agitation in patients undergoing Functional Endoscopic Sinus Surgery.

NCT ID: NCT03347916 Recruiting - Clinical trials for Emergence Agitation After Desflurane Anesthesia

Gabapentin Oral Solution in Decreasing Desflurane Associated Emergence Agitation

Start date: January 5, 2017
Phase: N/A
Study type: Interventional

to study the effect of oral gabapentin (5 mg/kg) on emergence agitation after desflurane anesthesia in pediatrics undergoing starbismus surgery

NCT ID: NCT02877108 Recruiting - Agitation Clinical Trials

Naturalistic Adasuve Clinical Trial Study

Start date: April 2016
Phase: Phase 1
Study type: Observational

There is limited information on the best psychoactive medication to treat agitated patients in the emergency department. The intent of this study is to fill in knowledge gaps in the current practice of treating psychiatric patients in the acute care setting. The purpose of this study is to determine the best treatment for agitated psychiatric patients in the emergency department.

NCT ID: NCT02617056 Recruiting - Dementia Clinical Trials

Objective Assessment of Behavioral Associations of Patients With Dementia

Start date: January 1, 2016
Phase:
Study type: Observational

It is generally acknowledged that patients with dementia are best cared for at home. However, outbursts of various behavioral disturbances, e.g., combativeness, appear in most cases and often necessitate institutionalization. These outbursts are often without apparent warning, which limits preventive interventions. The measurement of the electrical activity of the skin is well-studied as an indicator of stress or agitation. The investigators propose to monitor the electrical activity of skin in patients with dementia in order to determine whether any sign of agitation may occur before the outburst. If skin electrical activity gives sufficient warning, then preventive interventions may be tried. If successful, the ability to predict and prevent outbursts of behavioral disturbances will allow patients to be cared for at home for longer periods. It is the primary aim of this project to determine whether skin electrical activity gives such a warning; possible preventive measures will be the subject of future studies.

NCT ID: NCT02590744 Recruiting - Anesthesia Clinical Trials

Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery

Start date: October 2015
Phase: N/A
Study type: Interventional

This study is a single-center, prospective, randomized, controlled trial. To investigate if preoperative using of eye patch will decrease emergence agitation, and to provide a better method of decreasing emergence agitation to pediatric ophthalmic anesthesiologists.

NCT ID: NCT02446132 Recruiting - Clinical trials for Agitation in Patients With Dementia of the Alzheimer's Type

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Start date: December 2015
Phase: Phase 3
Study type: Interventional

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2 Study 12-AVR-131 to be included.